| Ident. | Authors (with country if any) | Title |
|---|
| 000071 (2013) |
Michel Engeln [France] ; Stefania Fasano [Italie] ; Serge H. Ahmed [France] ; Martine Cador [France] ; Veerle Baekelandt [Belgique] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France] | Levodopa gains psychostimulant‐like properties after nigral dopaminergic loss |
| 000089 (2013) |
Erwan Bezard [France] | Experimental reappraisal of continuous dopaminergic stimulation against L‐dopa‐induced dyskinesia |
| 000271 (2012) |
Sophie Schumm [France] ; Claude Sebban [France] ; Charles Cohen-Salmon [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Jean-Louis Golmard [France] ; Lydie Boussicault [France] ; Isabelle Petropoulos [France] ; Audrey Hild [France] ; Estelle Rousselet [France] ; Annick Prigent [France] ; Bertrand Friguet [France] ; Jean Mariani [France] ; Etienne C. Hirsch [France] | Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine |
| 000381 (2011) |
Kei Yamamoto [France] ; Jori O. Ruuskanen [France, Finlande] ; Mario F. Wullimann [Allemagne, France] ; Philippe Vernier [France] | Differential expression of dopaminergic cell markers in the adult zebrafish forebrain |
| 000507 (2010) |
Victoria E. Shaw [Australie] ; Sharon Spana [Australie] ; Keyoumars Ashkan [Royaume-Uni] ; Alim-Louis Benabid [France] ; Jonathan Stone [Australie] ; Gary E. Baker [Royaume-Uni] ; John Mitrofanis [Australie] | Neuroprotection of midbrain dopaminergic cells in MPTP‐treated mice after near‐infrared light treatment |
| 000553 (2010) |
David Devos [France] ; L. Defebvre [France] ; R. Bordet [France] | Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease |
| 000643 (2009) |
Renaud Massart [France] ; Jean-Philippe Guilloux [France] ; Virginie Mignon [France] ; Pierre Sokoloff [France] ; Jorge Diaz [France] | Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents |
| 000817 (2008) |
A. Marighetto ; S. Valerio [France] ; Jn Philippin [France] ; V. Bertaina-Anglade [France] ; C. Drieu La Rochelle [France] ; R. Jaffard [France] ; P. Morain [France] | Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents |
| 000905 (2007) |
Emilie Lacombe ; Carole Carcenac ; Sabrina Boulet ; Claude Feuerstein [France] ; Anne Bertrand ; Annie Poupard ; Marc Savasta [France] | High‐frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l‐3,4‐dihydroxyphenylalanine in dopaminergic denervated rats |
| 000B30 (2005) |
Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | End‐of‐dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: A pharmacokinetic/pharmacodynamic, randomized, double‐blind study |
| 000C73 (2003) |
Caroline Jan [France] ; Mathias Pessiglione [France] ; Léon Tremblay [France] ; Dominique Tandé [France] ; Etienne C. Hirsch [France] ; Chantal François [France] | Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP‐treated monkeys |
| 000E91 (2001) |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
| 000E95 (2001) |
Guillaume Lucas [France] ; Vincenzo Di Matteo [Italie] ; Philippe De Deurwaerdère [France] ; Grégory Porras [France] ; Raúl Martín-Ruiz [Espagne] ; Francesc Artigas [Espagne] ; Ennio Esposito [Italie] ; Umberto Spampinato [France] | Neurochemical and electrophysiological evidence that 5‐HT4 receptors exert a state‐dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function |
| 000F35 (2001) |
Catherine Verney [France] ; Nada Zecevic [États-Unis] ; Pascal Ezan [France] | Expression of calbindin D28K in the dopaminergic mesotelencephalic system in embryonic and fetal human brain |
| 000F50 (2001) |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
| 001070 (2000) |
Erwan Bezard [France] ; Sra Dovero [France] ; Christelle Imbert [France] ; Thomas Boraud [France] ; Christian E. Gross [France] | Spontaneous long‐term compensatory dopaminergic sprouting in MPTP‐treated mice |
| 001121 (2000) |
Màté Dàniel Döbrössy [France] ; Michel Le Moal [France] ; Marie-Francoise Montaron [France] ; Nora Abrous [France] | Influence of Environment on the Efficacy of Intrastriatal Dopaminergic Grafts |
| 001135 (2000) |
Pascal Barnéoud [France] ; Eric Descombris [France] ; Nadine Aubin [France] ; Djoher N. Abrous [France] | Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system |
| 001147 (2000) |
Chantal François [France] ; Claudine Savy [France] ; Caroline Jan [France] ; Dominique Tande [France] ; Etienne C. Hirsch [France] ; Jerome Yelnik [France] | Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP‐treated monkeys, and in Parkinson's disease patients |
| 001148 (2000) |
Caroline Jan [France] ; Chantal François [France] ; Dominique Tandé [France] ; Jérôme Yelnik [France] ; Léon Tremblay [France] ; Yves Agid [France] ; Etienne Hirsch [France] | Dopaminergic innervation of the pallidum in the normal state, in MPTP‐treated monkeys and in parkinsonian patients |
| 001322 (1999) |
Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di Paolo | Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys |
